A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma
Condition: Osteosarcoma Intervention: Drug: ALMB-0168 Sponsors: AlaMab Therapeutics (Shanghai) Inc.; CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials